The story conflated Trump's criticisms of Ireland with long-held industry concerns over the PBS. There is a world of difference, given that Trump is following Obama to reverse the impact of Ireland's low tax rate on the pharma industry, and recent US administrations have shown more interest in adopting PBS policies than seeking their elimination. …
In 2025, the US is more likely to adopt PBS pricing policies than oppose them
March 17, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Arthritis Australia unveils new grants and identity as research breakthroughs loom
July 16, 2026 - - Latest News -
Organon and Samsung Bioepis expand partnership to broaden biosimilar access in Australia
July 16, 2026 - - Latest News -
A single payer system in which the worst kind of inequity is the only one permitted
July 16, 2026 - - Latest News -
Algorae names Nasdaq pharmaceutical chairman to strengthen board
July 15, 2026 - - Australian Biotech -
Starpharma raises $32 Million to advance dendrimer cancer programs
July 15, 2026 - - Australian Biotech -
Minister recommits to keeping MS medicines on the PBS while awaiting formal advice
July 15, 2026 - - Latest News -
Budget outlook now hangs on disability savings, but what about pharmaceuticals
July 15, 2026 - - Latest News